# reload+after+2024-01-23 06:44:44.207673
address1§68 TW Alexander Drive
address2§PO Box 13628
city§Research Triangle Park
state§NC
zip§27709
country§United States
phone§919 636 4530
website§https://www.fennecpharma.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. The company's product candidates include PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity hearing loss in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.
fullTimeEmployees§36
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Rostislav  Raykov', 'age': 47, 'title': 'CEO & Director', 'yearBorn': 1976, 'fiscalYear': 2022, 'totalPay': 614161, 'exercisedValue': 0, 'unexercisedValue': 5722718}, {'maxAge': 1, 'name': 'Mr. Robert C. Andrade', 'age': 48, 'title': 'Chief Financial Officer', 'yearBorn': 1975, 'fiscalYear': 2022, 'totalPay': 428919, 'exercisedValue': 0, 'unexercisedValue': 2023772}, {'maxAge': 1, 'name': 'Mr. Adrian J. Haigh', 'age': 64, 'title': 'Chief Operating Officer', 'yearBorn': 1959, 'fiscalYear': 2022, 'totalPay': 40000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Mark  Gowland', 'title': 'Controller', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Lei  Fang', 'title': 'President of Pharstat Inc', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§9
boardRisk§5
compensationRisk§7
shareHolderRightsRisk§5
overallRisk§6
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§0.374
priceToSalesTrailing12Months§23.22779
currency§USD
dateShortInterest§1702598400
forwardEps§0.2
exchange§NCM
quoteType§EQUITY
shortName§Fennec Pharmaceuticals Inc.
longName§Fennec Pharmaceuticals Inc.
firstTradeDateEpochUtc§1505482200
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§c4d49e37-489f-3603-bf6e-9e09850463da
gmtOffSetMilliseconds§-18000000
targetHighPrice§17.0
targetLowPrice§15.0
targetMeanPrice§16.17
targetMedianPrice§16.0
recommendationMean§1.8
recommendationKey§buy
numberOfAnalystOpinions§6
quickRatio§4.325
grossMargins§0.94943
ebitdaMargins§0.0
trailingPegRatio§None
